Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of US-guided Alcohol Sclerotherapy for Endometriomas on Pelvic Pain and Quality of Life

NCT06955221 is registered in ClinicalTrials.gov with Hospital Universitari de Bellvitge as lead sponsor.

NCT NCT06955221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06955221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of US-guided Alcohol Sclerotherapy for Endometriomas on Pelvic Pain and Quality of Life
Lead sponsor
Hospital Universitari de Bellvitge
Phase
Not applicable
Overall status
Recruiting
Start date
January 1, 2025
Completion date
December 31, 2027
Enrollment
288 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

endometrioma, pelvic pain, quality of life, ultrasound therapy; complications